Bone Marrow Suppression and the Incidence of Infection of Pyrarubicin (THP) Combined Induction Therapy of Childhood Acute Lymphoblastic Leukemia.
スポンサーリンク
概要
- 論文の詳細を見る
We compared bone marrow suppression and the incidence of infection between patients who received pyrarubicin (THP) concomitantly with vincristine, prednisolone and L-asparaginase and patients who received adriamycin (ADM) concomitantly with vincristine, prednisolone and L-asparaginase for the induction of remission in childhood acute lymphoblastic leukemia. In the ADM group, the duration of neutropenia lower than 500/μ1 and lower than 200/μ1 was 13.7±9.9 days and 8.4±7.3 days, respectively. The duration of such neutropenia in the THP group, 23.9±5.1 days and 20.0±8.9 days, respectively, was significantly longer than that in the ADM group. In the ADM group, infection occurred in one of 12 patients, whereas, in the THP group, infection occurred in seven of 9 patients, and one patient died. The protocols had to be modified or interrupted in these seven patients. The incidence of infection in the two groups was significantly different. THP caused greater bone marrow suppression than ADM. Thus, we recommend strict prophylaxis for infections in patients who are to receive THP.
- 特定非営利活動法人 日本小児血液・がん学会の論文
特定非営利活動法人 日本小児血液・がん学会 | 論文
- The Parent's Emotional Adaptation to the Children's Malignant Disease
- Side Effect of Cranial Radiation in Childhood Acute Leukemia
- Red Blood Cell Volume Distribution Width in Normal Children and in the Patients with Various Kinds of Hematological Disorders.
- Effective Conditioning of Donors for Granulocyte Transfusions with Recombinant Human Granulocyte Colony-Stimulating Factor.
- Two Infant Girls of CNS Leukemia with Chronic Subdural Hematoma